COVID-19 vaccine will work against JN.1: Balram Bhargava – ET HealthWorld
Hyderabad : The newly detected JN.1 variant is not expected to spread in the country as the existing COVID-19 vaccines…
Fast News Hear
Hyderabad : The newly detected JN.1 variant is not expected to spread in the country as the existing COVID-19 vaccines…
KOLKATA: The state health department has allowed Covovax as a precautionary dose for all persons above 18 years of age…
Pune: The prevalent strain of COVID strain is mild and the Serum Institute of India (SII) has already produced five…
Pune: Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — COVID booster shot…
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine…
Covovax is manufactured through technology transfer from Novavax (Representational) New Delhi: In view of rising cases of COVID-19 in various…
New Delhi: In view of rising cases of COVID-19 in various parts of the country, Union health minister Mansukh Mandaviya…
New Delhi: Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry…
New Delhi: National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid-19 vaccine…
New Delhi: Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine…